✦ LIBER ✦

Pegylated liposomal doxorubicin and trastuzumab as 1st and 2nd line therapy in her2/neu positive metastatic breast cancer: a multicenter phase II trial

✍ Scribed by Elmar Stickeler; Maximilian Klar; Dirk Watermann; Annette Geibel; Martha Földi; Annette Hasenburg; Gerald Gitsch

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of pegylated liposomal do

✍ Antonio C. Wolff; Molin Wang; Hailun Li; Michael R. Pins; Florence J. Pretorius; 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 311 KB

Multicenter phase II study of trastuzuma

✍ M. Venturini; C. Bighin; S. Monfardini; F. Cappuzzo; N. Olmeo; A. Durando; F. Pu 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 218 KB

A phase II trial of trastuzumab plus wee

✍ Stacy Moulder; Hailun Li; Molin Wang; William J. Gradishar; Edith A. Perez; Jose 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 250 KB

A phase I/II prospective, single arm tri

✍ G. Somlo; C. L. Martel; S. K. Lau; P. Frankel; C. Ruel; L. Gu; A. Hurria; C. Chu 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 229 KB